X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (708) 708
lorazepam (622) 622
male (489) 489
adult (384) 384
female (363) 363
pharmacology & pharmacy (358) 358
benzodiazepines (268) 268
pharmacokinetics (244) 244
index medicus (242) 242
diazepam (225) 225
middle aged (189) 189
psychiatry (188) 188
lorazepam - administration & dosage (173) 173
lorazepam - pharmacology (151) 151
clinical neurology (150) 150
neurosciences (150) 150
double-blind method (146) 146
lorazepam - pharmacokinetics (140) 140
midazolam (139) 139
lorazepam - therapeutic use (119) 119
aged (117) 117
animals (117) 117
adolescent (115) 115
dose-response relationship, drug (107) 107
status epilepticus (91) 91
lorazepam - blood (86) 86
seizures (84) 84
kinetics (83) 83
benzodiazepine (80) 80
time factors (78) 78
hypnotics and sedatives - administration & dosage (75) 75
children (72) 72
lorazepam - adverse effects (71) 71
lorazepam - metabolism (71) 71
anticonvulsants - therapeutic use (70) 70
sedation (70) 70
anti-anxiety agents - pharmacology (68) 68
cross-over studies (68) 68
drug interactions (68) 68
psychomotor performance - drug effects (67) 67
alprazolam (66) 66
drugs (66) 66
half-life (65) 65
treatment outcome (63) 63
administration, oral (62) 62
epilepsy (61) 61
memory (61) 61
child (60) 60
pharmacodynamics (56) 56
infusions, intravenous (55) 55
status epilepticus - drug therapy (55) 55
anti-anxiety agents - therapeutic use (54) 54
pediatrics (54) 54
anticonvulsants - administration & dosage (53) 53
pharmacology (53) 53
analysis (51) 51
benzodiazepines - therapeutic use (51) 51
anti-anxiety agents - pharmacokinetics (50) 50
drug therapy (50) 50
anti-anxiety agents - metabolism (49) 49
management (49) 49
injections, intravenous (48) 48
hypnotics and sedatives - pharmacology (47) 47
lorazepam - analogs & derivatives (47) 47
young adult (47) 47
medicine & public health (46) 46
research (46) 46
pharmacology/toxicology (44) 44
care and treatment (43) 43
clinical trials (43) 43
dosage and administration (43) 43
hypnotics and sedatives - pharmacokinetics (43) 43
memory - drug effects (43) 43
anti-anxiety agents - adverse effects (42) 42
psychomotor performance (42) 42
cognition - drug effects (41) 41
neurology (41) 41
rats (41) 41
child, preschool (40) 40
propofol (40) 40
seizures - drug therapy (40) 40
anxiety (39) 39
clinical pharmacokinetics (39) 39
double-blind (39) 39
hypnotics and sedatives - therapeutic use (39) 39
hypnotics and sedatives - adverse effects (38) 38
infant (38) 38
mice (38) 38
diazepam - administration & dosage (37) 37
gaba (37) 37
healthy-volunteers (37) 37
metabolism (37) 37
benzodiazepines - administration & dosage (36) 36
biomedicine (36) 36
patients (36) 36
placebo (36) 36
triazolam (36) 36
analysis of variance (35) 35
anti-anxiety agents - administration & dosage (35) 35
anticonvulsants - pharmacokinetics (35) 35
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (956) 956
German (10) 10
French (6) 6
Japanese (4) 4
Spanish (2) 2
Czech (1) 1
Danish (1) 1
Italian (1) 1
Polish (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2001, Volume 15, Issue 6, 26
Many psychiatric patients smoke, and are believed to be heavier smokers than those without psychiatric disorders. Cigarette smoking is one of the environmental... 
Chlordiazepoxide, pharmacokinetics | Risperidone, pharmacokinetics | Amitriptyline, pharmacokinetics | Lorazepam, pharmacokinetics | Serotonin reuptake inhibitors, pharmacokinetics | Amfebutamone, pharmacokinetics | Haloperidol, pharmacokinetics | Fluphenazine, pharmacokinetics | Diazepam, pharmacokinetics | Trazodone, pharmacokinetics | Imipramine, pharmacokinetics | Clozapine, pharmacokinetics | Trifluoperazine, pharmacokinetics | Tricyclic antidepressants, pharmacokinetics | Clomipramine, pharmacokinetics | Zotepine, pharmacokinetics | Tiotixene, pharmacokinetics | Alprazolam, pharmacokinetics | Nortriptyline, pharmacokinetics | Fluvoxamine, pharmacokinetics | Venlafaxine, pharmacokinetics | Antidepressants, pharmacokinetics | Triazolam, pharmacokinetics | Chlorpromazine, pharmacokinetics | Olanzapine, pharmacokinetics | Antipsychotics, pharmacokinetics | Anxiolytics, pharmacokinetics | Smoking | Pharmacotherapy | Neurology | Neurosciences | Medicine & Public Health | Psychiatry | Psychopharmacology | VARIABILITY FACTORS | TOBACCO SMOKING | CIGARETTE-SMOKING | REDUCED HALOPERIDOL | PSYCHIATRIC POPULATION | DEPRESSED-PATIENTS | PLASMA-CONCENTRATIONS | DRUG-INTERACTIONS | CYP1A2 GENE | PHARMACOLOGY & PHARMACY | TARDIVE-DYSKINESIA | NEUROSCIENCES | Smoking - metabolism | Animals | Drug Interactions | Mental Disorders - drug therapy | Psychotropic Drugs - pharmacokinetics | Humans | Mental Disorders - metabolism | Smoking - psychology
Book Review
Acta Neurologica Scandinavica, ISSN 1600-0404, 08/2008, Volume 118, Issue 2, pp. 69 - 86
Journal Article
Book Review
Book Review
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 08/2017, Volume 56, Issue 8, pp. 941 - 951
Journal Article